Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers-Reference-Cited by-同舟云学术

Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers

Published:2013-07 Issue:7 Volume:30 Page:659-670
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Madsen Bjørn S.,Havelund Troels,Krag Aleksander

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-013-0044-1.pdf

Reference102 articles.

1. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–51.

2. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–31.

3. Nolan JP. The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology. 2010;52:1829–35.

4. Worlicek M, Knebel K, Linde HJ, et al. Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis. Gut. 2010;59:1127–34.

5. Xu WH, Wu XJ, Li JS. Influence of portal pressure changes on intestinal permeability in patients with portal hypertension. Hepatobiliary Pancreat Dis Int. 2002;1:510–4.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities;International Journal of Molecular Sciences;2024-05-28

2. The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension;2024-03-29

3. Liver cirrhosis and complications from the perspective of dysbiosis;Frontiers in Medicine;2024-01-16

4. The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status;Diagnostics;2023-09-15

5. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial;The Lancet Gastroenterology & Hepatology;2023-06